American Journal of Clinical Pathology · 2011 · 29 citations · 15 references
MedicineOncologyBreast OncologyComparative OncologyTumor PathologyBreast PathologyHer2-positive Breast CancerImmunohistochemistryTumor AntigensTumor-associated AntigensDiagnostic ImmunohistochemistryFalse Negative DetectionFalse Negative Rate AnalysisImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingMonoclonal Antibodies In Oncology
HER2/neu status in breast cancer is determined by immunohistochemical analysis and/or fluorescence in situ hybridization (FISH). Previous studies have found widely varying sensitivities and specificities for anti-HER2/neu antibodies, including recently developed rabbit monoclonal antibodies. The current prospective study compared rabbit monoclonal antibody SP3 and rabbit polyclonal antibody A0485 immunostaining on routinely processed consecutive cases of breast carcinoma. Of 1,610 cases tested, 261 (16.2%) equivocal (2+) cases were evaluated by FISH. Of 253 cases equivocal with A0485 results, 125 (49.4%) were negative with SP3. In 22 (8.7%) of 253 cases equivocal with A0485, there was amplification by FISH, and 3 of these cases were SP3- (0/1+). Of the 20 (14.8%) of 135 SP3-equivocal cases amplified by FISH, 1 case was A0485-. The reported false-negative rate with A0485 is 2.8%, and the American Society of Clinical Oncology/College of American Pathologists guidelines recommend a rate of less than 5%. Compared with A0485, the false-negative rate with SP3 is only 0.3% (3/1,156) higher, but it shows about a 50% reduction in equivocal scores, reducing the need for reflex FISH testing.
15
Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text
HER-2 Testing in Breast Cancer Using Parallel Tissue-Based Methods
Hadi Yaziji · JAMA · 2004 · 449 citations
Annette Lebeau, Daniela Deimling, Christine Kaltz et al. · Journal of Clinical Oncology · 2001 · 326 citations
Caterina Marchiò, Maryou Lambros, Patrizia Gugliotta et al. · The Journal of Pathology · 2009 · 201 citations · Full text
Life Sciences, Genetics, Oncology +16